Ebola vaccine trial interrupted for checks after joint pains - Geneva hospital
11 December 2014, 22:55
Geneva - A clinical trial of the Ebola vaccine by Merck and NewLink has been interrupted in all 59 volunteers in Geneva a week early "as a measure of precaution" after four patients complained of joint pains in hands and feet, the University of Geneva Hospital said on Thursday.
Also read: Mother
has a strange craving for toilet paper
"They are all fine and being monitored regularly by the medical team leading the study," it said in a statement.
The human safety trials are due to resume on Jan. 5 in up to 15 volunteers after checks to ensure that the joint pain symptoms were "benign and temporary", the hospital said.